| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-12 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.29 | 5e-07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |